Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecularly Targeted Therapy towards Genetic Alterations in Advanced Bladder Cancer
Jonathan Thomas, Guru Sonpavde
Cancers (2022) Vol. 14, Iss. 7, pp. 1795-1795
Open Access | Times Cited: 23

Showing 23 citing articles:

Advances in diagnosis and treatment of bladder cancer
Antonio López-Beltrán, Michael S. Cookson, Brendan J. Guercio, et al.
BMJ (2024), pp. e076743-e076743
Open Access | Times Cited: 139
The Impact of FGFR3 Alterations on the Tumor Microenvironment and the Efficacy of Immune Checkpoint Inhibitors in Bladder Cancer
Kazumasa Komura, Kensuke Hirosuna, Satoshi Tokushige, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 18
Experience of Next-Generation Sequencing in urothelial carcinoma specimens with panel for 523 genes
Ya. V. Gridneva, D. N. Khmelkova, М. И. Волкова, et al.
Journal of Modern Oncology (2025) Vol. 26, Iss. 4, pp. 489-494
Open Access
The Role of Cell-Free DNA in Cancer Treatment Decision Making
András Telekes, Anna Horváth
Cancers (2022) Vol. 14, Iss. 24, pp. 6115-6115
Open Access | Times Cited: 21
Current and Emerging Strategies to Treat Urothelial Carcinoma
Berkha Rani, James J. Ignatz-Hoover, Priyanka S. Rana, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4886-4886
Open Access | Times Cited: 9
Urine-derived bladder cancer organoids (urinoids) as a tool for cancer longitudinal response monitoring and therapy adaptation
Bastiaan J. Viergever, Daniëlle Raats, Veerle Geurts, et al.
British Journal of Cancer (2023) Vol. 130, Iss. 3, pp. 369-379
Open Access | Times Cited: 9
Navigating the Rapidly Evolving Advanced Urothelial Carcinoma Treatment Landscape: Insights from Italian Experts
Daniele Santini, Giuseppe Luigi Banna, Sebastiano Buti, et al.
Current Oncology Reports (2023) Vol. 25, Iss. 11, pp. 1345-1362
Open Access | Times Cited: 7
Tackling FGFR3-driven bladder cancer with a promising synergistic FGFR/HDAC targeted therapy
Zechen Wang, Viswanathan Muthusamy, Daniel P. Petrylak, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 6
Identification of a naturally-occurring canine model for early detection and intervention research in high grade urothelial carcinoma
Deepika Dhawan, José A. Ramos‐Vara, Sagar M. Utturkar, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 10
Antibody–drug conjugates in urothelial carcinoma: scientometric analysis and clinical trials analysis
Meng Zhang, Yuxiao Zuo, Si–Yi Chen, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Landscape of targeted therapies for advanced urothelial carcinoma
S. Y. Shang, Lei Zhang, Kepu Liu, et al.
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 3, pp. 641-677
Open Access | Times Cited: 1
The Role of Fibroblast Growth Factor Receptors Inhibitors in Bladder Cancer
Ho Kyung Seo, Eui Jung, Sora Yang, et al.
Journal of Urologic Oncology (2024) Vol. 22, Iss. 2, pp. 166-177
Closed Access | Times Cited: 1
New Advances in Metastatic Urothelial Cancer: A Narrative Review on Recent Developments and Future Perspectives
Elena Tonni, Marco Oltrecolli, Marta Pirola, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9696-9696
Open Access | Times Cited: 1
FGFR Inhibitors in Urothelial Cancer: From Scientific Rationale to Clinical Development
Whi‐An Kwon
Journal of Korean Medical Science (2024) Vol. 39, Iss. 43
Open Access | Times Cited: 1
Deciphering the molecular heterogeneity of intermediate- and (very-)high-risk non–muscle-invasive bladder cancer using multi-layered –omics studies
Murat Akand, Tatjana Jatsenko, Tim Muilwijk, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Sulforaphane and bladder cancer: a potential novel antitumor compound
Mingshun Zuo, Chen Hong-chuan, Yuanjian Liao, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 1
The Potential of Congo Red Supplied Aggregates of Multitargeted Tyrosine Kinase Inhibitor (Sorafenib, BAY-43-9006) in Enhancing Therapeutic Impact on Bladder Cancer
Małgorzata Lasota, Daniel Jankowski, Anna Wiśniewska, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 269-269
Open Access | Times Cited: 1
Clinical implications and practical considerations for poly-ADP-ribose polymerase inhibitors as a new horizon for the management of urothelial carcinoma of the bladder
Hye Won Lee, Ho Kyung Seo
Investigative and Clinical Urology (2022) Vol. 63, Iss. 4, pp. 369-369
Open Access | Times Cited: 1
Urine-derived bladder cancer organoids (urinoids) as tool for cancer longitudinal response monitoring and therapy adaptation
Bastiaan J. Viergever, Daniëlle Raats, Veerle Geurts, et al.
Research Square (Research Square) (2023)
Open Access
Clinical Exome Gene Panel Analysis of a Cohort of Urothelial Bladder Cancer Patients from Sri Lanka
Ajith Malalasekera, Nilaksha Neththikumara, Somasundaram Praveenan, et al.
Asian Pacific Journal of Cancer Prevention (2023) Vol. 24, Iss. 5, pp. 1533-1542
Open Access
Metastatic urothelial carcinoma: later-line therapy
Johanna Krauter, Kilian M. Gust, Shahrokh F. Shariat
Journal für Urologie und Urogynäkologie/Österreich (2023) Vol. 30, Iss. 2, pp. 60-65
Open Access
Molecular Pathology of Urinary Bladder Tumors
George J. Netto, Liang Cheng
Springer eBooks (2023), pp. 401-422
Closed Access
Frequency of next-generation sequencing, prevalence of targetable mutations and response to targeted therapies amongst patients with metastatic urothelial cancer in Ireland: a multi-centre retrospective study of real-world data
Karine Ronan, Emmet Jordan, Christine Léonard, et al.
Irish Journal of Medical Science (1971 -) (2023) Vol. 193, Iss. 3, pp. 1155-1161
Closed Access
Page 1

Scroll to top